RIVN
Rivian Automotive, Inc.
RIVN's outlook is improving, though it still trails on the overall score.
SGHC
Super Group (SGHC) Limited
SGHC has the edge over RIVN overall, supported by stronger modeled upside and stronger valuation.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SGHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Strong |
SGHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
SGHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $4.10 | -64% |
| Forward | 13x | $11.42 | — |
| Current | 16x | $11.42 | — |
| Fair | 23x | $16.77 | +47% |
| Expensive | 52x | $37.98 | +233% |
Historical ranges are pointers, not guarantees.
SGHC's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SGHC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for SGHC, with profitability improving.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
SGHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.87 | +19% |
| Q2 2026 | $0.73 | +161% |
| Q1 2026 | $0.48 | +66% |
| Q4 2025 | $0.44 | +69% |
| Q3 2025 | $0.46 | +2200% |
| Q2 2025 | $0.28 | +1300% |
| Q1 2025 | $0.29 | +262% |
| Q4 2024 | $0.26 | +$0.28 |
| Q3 2024 | $0.02 | -80% |
SGHC has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
SGHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $684M | +0.3% |
| Q1 2026 | $612M | +8% |
| Q4 2025 | $578M | +21% |
| Q3 2025 | $555.7M | +11% |
| Q2 2025 | $681.7M | +48% |
| Q1 2025 | $566.8M | +24% |
| Q4 2024 | $476.5M | +19% |
| Q3 2024 | $499.8M | +26% |
SGHC has the edge over RIVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 25% | +7 points |
| Q1 2026 | 20% | +2.7 points |
| Q4 2025 | 17% | -4.2 points |
| Q3 2025 | 25% | +20 points |
| Q2 2025 | 18% | +4.5 points |
| Q1 2025 | 17% | +12 points |
| Q4 2024 | 22% | +23 points |
| Q3 2024 | 5.5% | -2.3 points |
SGHC has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
SGHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $164M | +$286.3M |
| Q1 2026 | $89M | -63% |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$122.3M | -$122.3M |
| Q1 2025 | $241M | +$241M |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
SGHC has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SGHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +2.8M shares |
| 1 year | +1.9% | +9.3M shares |
| 3 years | +2.2% | +11.2M shares |
| 5 years | +4.6% | +22.4M shares |
SGHC has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
SGHC hasn't bought back shares in the past year.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SGHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -1.8x | Net Cash |
SGHC has more cash than debt.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
SGHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 19.2 | Oversold |
SGHC's weekly RSI is 42 (neutral) and its Stochastic is 19 (oversold).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
SGHC PE vs Consumer Cyclical Sector
| Metric | SGHC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 34 | 49 | 15 pts below |
SGHC is trading at 16x earnings, a 13% discount to the Consumer Cyclical sector's median of 18x.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
SGHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.2 | 1.6% above |
| 20 week MA | $12.8 | 11% below |
| 50 week MA | $12.0 | 4.6% below |
| 100 week MA | $10.8 | 6.1% above |
| 200 week MA | $7.19 | 59% above |
SGHC has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
SGHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.73 | $10.2 | +4.6% |
| 2021 | $10.2 | $9.96 | -2.2% |
| 2022 | $9.96 | $2.96 | -70% |
| 2023 | $2.96 | $3.17 | +7.1% |
| 2024 | $3.17 | $6.10 | +92% |
| 2025 | $6.10 | $11.9 | +95% |
| 2026 YTD | $11.9 | $11.4 | -4.2% |
SGHC has the edge over RIVN on returns for 2026, with the stronger performance.